Zobrazeno 1 - 10
of 199
pro vyhledávání: '"Nathaniel M, Hawkins"'
Autor:
Isaac Robinson, Daniel Daly-Grafstein, MSc, Mayesha Khan, MA, Andrew D. Krahn, MD, Nathaniel M. Hawkins, MD, Jeffrey R. Brubacher, MD, John A. Staples, MD, MPH
Publikováno v:
CJC Open, Vol 6, Iss 7, Pp 876-883 (2024)
Background: Administrative health data and cardiac device registries can be used to empirically evaluate outcomes and costs after implantable cardioverter defibrillator (ICD) implantation. These datasets often have incomplete information on the indic
Externí odkaz:
https://doaj.org/article/c77f3f49e7464aae889a776e229a57f6
Autor:
Christina L. Luong, Mohammad H. Jafari, Delaram Behnami, Yaksh R. Shah, Lynn Straatman, Nathan Van Woudenberg, Leah Christoff, Nancy Gwadry, Nathaniel M. Hawkins, Eric C. Sayre, Darwin Yeung, Michael Tsang, Ken Gin, John Jue, Parvathy Nair, Purang Abolmaesumi, Teresa Tsang
Publikováno v:
Echo Research and Practice, Vol 11, Iss 1, Pp 1-10 (2024)
Abstract Background Machine learning (ML) algorithms can accurately estimate left ventricular ejection fraction (LVEF) from echocardiography, but their performance on cardiac point-of-care ultrasound (POCUS) is not well understood. Objectives We eval
Externí odkaz:
https://doaj.org/article/06b6ab0181114a9fa135c0ffd67756ca
Autor:
Roopinder K. Sandhu, MD, MPH, Hena Qureshi, MSc, Heather Halperin, BSc, Douglas C. Dover, PhD, Nathan Klassen, MA, Nathaniel M. Hawkins, MD, Jason G. Andrade, MD, Padma Kaul, PhD
Publikováno v:
CJC Open, Vol 6, Iss 2, Pp 407-416 (2024)
Background: Healthcare resource use for atrial fibrillation (AF) is high, but it may not be equivalent across all patients. We examined whether sex differences exist for AF high-cost users (HCUs), who account for the top 10% of total acute care costs
Externí odkaz:
https://doaj.org/article/541fe63b121046b4b17310d8f725b359
Autor:
Nathaniel M. Hawkins, Sandra Peterson, Samaneh Salimian, Catherine Demers, Karim Keshavjee, Sean A. Virani, G.B. John Mancini, Sabrina T. Wong
Publikováno v:
ESC Heart Failure, Vol 10, Iss 6, Pp 3612-3621 (2023)
Abstract Aims Heart failure (HF) and chronic obstructive pulmonary disease (COPD) are largely managed in primary care, but their intersection in terms of disease burden, healthcare utilization, and treatment is ill‐defined. Methods and results We e
Externí odkaz:
https://doaj.org/article/1caa0ab5ff864d16a8d66dd304d576f8
Autor:
Haran Yogasundaram, MD, MSc, Sunjidatul Islam, MBBS, MSc, Douglas C. Dover, PhD, Nathaniel M. Hawkins, MBChB, MD, MPH, Justin Ezekowitz, MBBCh, MSc, Padma Kaul, PhD, Roopinder K. Sandhu, MD, MPH
Publikováno v:
CJC Open, Vol 4, Iss 8, Pp 701-708 (2022)
Background: Heart failure (HF) is a leading complication of nonvalvular atrial fibrillation (NVAF), and the presence of both conditions worsens prognosis. Sex-specific associations between NVAF and outcomes focus on stroke; less is known about HF. We
Externí odkaz:
https://doaj.org/article/2b769f4df02a4a6eac34063e80ce15dd
Autor:
Stephanie Poon, MD, MSc, FRCPC, Benjamin Leis, MD, FRCPC, Laurie Lambert, PhD, Kendra MacFarlane, MSc, Kim Anderson, MD, MSc, FRCPC, Claudia Blais, PhD, Catherine Demers, MD, MSc, FRCPC, Justin A. Ezekowitz, MBBCh, MSc, Nathaniel M. Hawkins, MBChB, MD, MPH, Douglas S. Lee, MD, PhD, FRCPC, Gordon Moe, MSc, MD, FRCPC, FAHA, FACC, Roopinder K. Sandhu, MD, MPH, MSc, Sean A. Virani, MD, MSc, MPH, FRCPC, FCCS, Stephen Wilton, MD, MSc, Shelley Zieroth, MD, FRCPC, Robert McKelvie, MD, PhD, FRCPC
Publikováno v:
CJC Open, Vol 4, Iss 8, Pp 667-675 (2022)
Background: An unanswered question is whether the combination of advances in medical and device therapy over the past decade has translated into improved outcomes for patients with heart failure (HF) in Canada. Methods: The Canadian Institute for Hea
Externí odkaz:
https://doaj.org/article/cd70910f16b44126af925594df915105
Autor:
Jennifer K Quint, Hana Müllerova, Clementine Nordon, Nathaniel M Hawkins, Jonathan Marshall, Sami O Simons, Kirsty Rhodes, Claus F Vogelmeier, Mario Ouwens, Edeltraut Garbe
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Introduction In patients with chronic obstructive pulmonary disease (COPD), the risk of certain cardiovascular (CV) events is increased by threefold to fivefold in the year following acute exacerbation of COPD (AECOPD), compared with a non-exacerbati
Externí odkaz:
https://doaj.org/article/3a655a09a54045f5bc0daaeae73be741
Autor:
Sina Safabakhsh, BSc, Darson Du, MD, Janet Liew, BSc, Jeremy Parker, PhD, Cheryl McIlroy, BSN, Elina Khasanova, MD, Praveen Indraratna, MD, Philipp Blanke, MD, Jonathon Leipsic, MD, Jason G. Andrade, MD, Matthew T. Bennett, MD, Nathaniel M. Hawkins, MBChB, MD, Shantabanu Chakrabarti, MD, John Yeung, MD, Marc W. Deyell, MD, Andrew D. Krahn, MD, FHRS, Robert Moss, MD, Kevin Ong, MD, Zachary Laksman, MD, MSc
Publikováno v:
CJC Open, Vol 4, Iss 3, Pp 305-314 (2022)
Background: Sudden cardiac death (SCD) risk stratification in hypertrophic cardiomyopathy (HCM) currently relies on arrhythmic burden quantification by 24 or 48-hour Holter monitoring. Whether this approach adequately captures arrhythmic burden, comp
Externí odkaz:
https://doaj.org/article/c1170a9da7514c05b8db6278b2e4971f
Autor:
Thomas M. Roston, MD, PhD, Sunjidatul Islam, MBBS, MSc, Nathaniel M. Hawkins, MBChB, MD, MPH, Zachary W. Laksman, MD, MSc, Shubhayan Sanatani, MD, Andrew D. Krahn, MD, Roopinder Sandhu, MD, MPH, Padma Kaul, PhD
Publikováno v:
CJC Open, Vol 4, Iss 1, Pp 65-74 (2022)
Background: Previous studies on lone/unexplained atrial fibrillation and atrial flutter (AF) did not exclude patients with contemporary secondary AF triggers. We characterized unexplained AF using a strict definition, and compared it to secondary AF.
Externí odkaz:
https://doaj.org/article/01e36a15d80c4dd6a1d1d0661d983825
Autor:
Samaneh Salimian, PhD, Marc W. Deyell, MD, MSc, FHRS, Jason G. Andrade, MD, FHRS, Santabhanu Chakrabarti, MBChB, Matthew T. Bennett, MD, FHRS, Andrew D. Krahn, MD, FHRS, Nathaniel M. Hawkins, MBChB, MD, MPH
Publikováno v:
Heart Rhythm O2, Vol 2, Iss 6, Pp 698-709 (2021)
Background: Heart failure and reduced ejection fraction (HFrEF) is the predominant indication for cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) implantation. The care gap and opportunity to optimize guidelin
Externí odkaz:
https://doaj.org/article/b1ae47925fa342d9ae4213cec9a57b94